Dergiler / Psychiatry and behavioral sciences (Online) / 2018 / Cilt: 8 - Sayı: 4

Risperidone-induced Enuresis Continuum in Two Pediatric Cases

Sayfa
208–212
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Considering also the adverse impact of urinary incontinence of patients’ quality of life, it is important for clinicians to be aware of such a side-effect in order to increase compliance with treatment in patients

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Risperidone is an atypical antipsychotic agent, widely used in the management of anger, aggression, and behavioral problems in children and adolescents.
📊
Temel Bulgular & Veri:Its use in children and adolescents is safe, and the most frequently reported side-effects are weight gain, listlessness, and increased appetite.
💡
Sonuç & Katkı:Considering also the adverse impact of urinary incontinence of patients’ quality of life, it is important for clinicians to be aware of such a side-effect in order to increase compliance with treatment in patients
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Risperidone is an atypical antipsychotic agent, widely used in the management of anger, aggression, and behavioral problems in children and adolescents. Its use in children and adolescents is safe, and the most frequently reported side-effects are weight gain, listlessness, and increased appetite. Enuresis is a rare complication following risperidone use. This report describes two pediatric cases of enuresis developing following a risperidone use. The first case was a 9-year-old boy diagnosed with attention-deficit/ hyperactivity disorder with combined presentation and oppositional defiant disorder. Diurnal and nocturnal enuresis began on the fifth day of 0.5 mg risperidone therapy and resolved four days after discontinuation of risperidone. The second patient was a 13-year-old boy diagnosed with Down syndrome, intellectual disability, and conduct disorder. Diurnal and nocturnal enuresis started on the third day of 1 mg/day risperidone therapy and resolved 10 days after discontinuation of risperidone. Both patients were subsequently started on aripiprazole, with a low α-1 adrenergic blocking effect, and no enuresis occurred during their follow-up visits. Cases of both nocturnal and diurnal enuresis following risperidone use are rare in the previous literature. In addition to the central dopamine blocking caused by antipsychotics, mechanisms such as peripheral α-blockage involvement in relaxation of the urethral muscles and blocking of the pudendal muscles with 5-HT2 and 5-HT3 antagonism have also been implicated in urinary incontinence. This report is important in terms of emphasizing the rare side-effect of both nocturnal and diurnal enuresis following a risperidone use. Considering also the adverse impact of urinary incontinence of patients’ quality of life, it is important for clinicians to be aware of such a side-effect in order to increase compliance with treatment in patients

🔖

Bu Makaleye Atıf Yap

KILIÇASLAN, F., AYAYDIN, H., GÜNGÖRDÜ, E., SEVGEN, F. H. (2018). Risperidone-induced Enuresis Continuum in Two Pediatric Cases. Psychiatry and behavioral sciences (Online), Cilt: 8 - Sayı: 4, 208–212. https://ajindex.com/articles/302827

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Erermis S, Aydin C. Çocuk ruh sağlığı yönünden enüresis. Ben Hasta Değilim, A Ekşi (Ed) Nobel Tıp Kitabevleri; 1999, p. 109- 118. (Turkish
  2. Barnes TR, Drake MJ, Paton C. Nocturnal enuresis with antipsychotic medication. Br J Psychiatry 2012;200(1):7-9
  3. Harrison-Woolrych M, Skegg K, Ashton J, Herbison P, Skegg DC. Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. Br J Psychiatry 2011;199(2):140-4
  4. Dikshit R, Karia S, De Sousa A. Risperidone-induced Enuresis in a 12-year-old Child. J Neurosci Rural Pract 2017;8(1):122-3
  5. Ayaydin H, Ulgar SB. Diurnal enuresis developing in association with risperidone and aripiprazole use in a child with autism spectrum disorder: a case report. Psychiatry and Clinical Psychopharmacology 2018;28(3):329-31
  6. Hergüner S, Mukaddes NM. Risperidone-induced enuresis in two children with autistic disorder. J Child Adolesc Psychopharmacol 2007;17(4):527-530
  7. Herguner S, Mukaddes NM. Risperidone-induced double incontinence. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(4):1085-6
  8. Troost PW, Lahuis BE, Steenhuis MP, Ketelaars CEJ, Buitelaar JK, Van Engeland H, et al. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. J Am Acad Child Adolesc Psychiatry 2005;44(11):1137-44
  9. Stigler KA, Potenza MN, McDougle CJ. Tolerability profile of atypical antipsychotics in children and adolescents. Paediatr Drugs 2001;3(12):927-42
  10. Ghanizadeh A, Kianpoor M. Cessation of risperidoneinduced incontinency by valproate in a child with pervasive developmental disorder. Prim Psychiatry 2007;15(4):32-4
  11. Kose S, Akin E, Cetin M. Adverse drug reactions and causality: the Turkish version of Naranjo adverse drug reactions probability scale. Psychiatry Clin Psychopharmacol 2017;27(2):205–6
  12. Aronowitz JS, Safferman AZ, Lieberman JA. Management of clozapine-induced enuresis. Am J Psychiatry 1995;152(3):472
  13. Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry 1996;57(11):514-8
  14. Vera PL, Alejandro MS, Irving N. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BMC Pharmacol 2001;1(1):1-14
  15. Ambrosini PJ. A pharmacological paradigm for urinary incontinence and enuresis. J Cl